Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

203.34
+0.24000.12%
Post-market: 203.00-0.3400-0.17%19:45 EDT
Volume:1.48M
Turnover:301.21M
Market Cap:10.45B
PE:32.22
High:205.81
Open:201.84
Low:201.12
Close:203.10
52wk High:217.12
52wk Low:149.09
Shares:51.40M
Float Shares:51.40M
Volume Ratio:0.77
T/O Rate:2.87%
Dividend:0.35
Dividend Rate:0.17%
EPS(TTM):6.31
EPS(LYR):35.34
ROE:24.54%
ROA:0.10%
PB:1.28
PE(LYR):5.75

Loading ...

Nurix - to Receive $10 Mln Research Term Extension Fee

THOMSON REUTERS
·
Oct 05

Nurix - Retains Co-Development and 50/50 Profit Sharing Options on Two U.S. Programs

THOMSON REUTERS
·
Oct 05

One Weekend, Thousands Of Compounds: Inside Microsoft's New AI Biology Model

AI Industry Frontlines
·
Oct 03

Gilead CEO Daniel O’Day Disposes of USD 2,216,507.50 in Common Shares

Reuters
·
Oct 03

Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Oct 03

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Oct 03

Sector Update: Healthcare

MT Newswires Live
·
Oct 03

Exchange-Traded Funds Rise as US Equities Advance After Midday

MT Newswires Live
·
Oct 03

Legend Biotech Faces Pressure From Rivals Ahead of Key FDA Decision, UBS Says

MT Newswires Live
·
Oct 03

Amgen’s Evolocumab Study Signals Quiet Efficiency Gains for Cholesterol Franchise

TIPRANKS
·
Oct 03

European Equities Traded in the US as American Depositary Receipts Track Higher in Friday Trading

MT Newswires Live
·
Oct 02

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday Amid Jobs Data

MT Newswires Live
·
Oct 02

Analysts Have Conflicting Sentiments on These Healthcare Companies: TransMedics Group (TMDX), Regeneron (REGN) and Tarsus Pharmaceuticals (TARS)

TIPRANKS
·
Oct 02

Press Release: Celcuity Appoints David Gryska to Its Board of Directors

Dow Jones
·
Oct 02

Piper Sandler Remains a Buy on Regeneron (REGN)

TIPRANKS
·
Oct 02

Abogen announces licensing, option agreement with Novartis

TIPRANKS
·
Oct 02

Major Drugmakers Turn to China for Licensing Deals

Reuters
·
Oct 02

Sanofi, Regeneron's Dupixent Successors Might Fall Short of Rivals

Dow Jones
·
Oct 02

Analysts’ Top Healthcare Picks: Regeneron (REGN), Idexx Laboratories (IDXX)

TIPRANKS
·
Oct 02

Vertex Minerals lodges 2026 corporate governance statement with ASX

TIPRANKS
·
Oct 02